Related Experiment Video
Updated: Jan 3, 2026
Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
Immunization Strategies for the Control of Histoplasmosis
Maxwell T Roth1, Daniel Zamith-Miranda1, Joshua D Nosanchuk1
1Department of Medicine (Division of Infectious Diseases) and Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Abstract:
Histoplasmosis is an infection caused by the dimorphic fungus Histoplasma capsulatum. Histoplasmosis is typically self-limited and presents asymptomatically in most people. Nevertheless, histoplasmosis can cause severe pulmonary disease and death. Histoplasmosis is increasingly found worldwide; however, it is best documented in the endemic region of the Mississippi river valley system in the Eastern part of the United States (US). Epidemiological studies from the US detailing the morbidity, mortality, and cost associated with histoplasmosis underscore the need to develop a vaccine.
Purpose Of Review:
This review will detail some of the major developments in potential vaccines against histoplasmosis, with particular emphasis on those that could be used to immunize immunocompromised hosts. Additionally, this review will highlight some non-traditional vaccine-like ideas for the prevention of diverse mycoses.
Recent Findings:
Historically, immunization strategies against histoplasmosis have largely focused on identifying immunogenic proteins that confer protection in animal models. More recently, novel active, therapeutic, and immunomodulatory strategies have been explored as potential alternatives for those with various immune-deficiencies.
Summary:
The studies summarized in this review demonstrate that more research is needed to clarify the immunobiology, clinical role and efficacy of each candidate vaccine in the ever-expanding potential armamentarium against histoplasmosis.
Insights
Developing a vaccine for Histoplasmosis, a fungal infection, is crucial due to its severe potential. Research is exploring novel strategies, especially for immunocompromised individuals, to combat this global health concern.
Area of Science:
- Mycology
- Immunology
- Infectious Diseases
Background:
- Histoplasmosis is a fungal infection caused by *Histoplasma capsulatum*.
- While often asymptomatic, it can lead to severe pulmonary disease and death.
- Endemic in the US Mississippi river valley, it's a growing global concern.
Purpose of the Study:
- To review developments in potential vaccines against histoplasmosis.
- To emphasize vaccines for immunocompromised hosts.
- To highlight non-traditional approaches for mycoses prevention.
Main Methods:
- Review of historical and recent immunization strategies.
- Exploration of novel active, therapeutic, and immunomodulatory approaches.
- Focus on strategies applicable to immunocompromised individuals.
Main Results:
- Historical strategies focused on immunogenic proteins in animal models.
- Recent research explores novel therapeutic and immunomodulatory strategies.
- These new approaches offer alternatives for immunocompromised individuals.
Conclusions:
- Further research is essential to understand vaccine immunobiology and efficacy.
- Clarifying the clinical role of candidate vaccines is necessary.
- An expanding armamentarium against histoplasmosis requires continued investigation.
Related Concept Videos
01:22Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:10Retrovirus Life Cycles
01:25Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
01:36Humoral Immune Responses